Rycarfa Tablets for Dogs contain Carprofen and are used for reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. Rycarfa tablets can also be used as a follow up to parenteral analgesia in the management of post operative pain. Contraindications: Do not use in cats. Do not use in pregnant or lactating bitches. Do not use in dogs less than 4 months of age. Do not use in case of hypersensitivity to active substance or to any of the excipients. Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia. There is no specific antidote for carprofen overdosage but general supportive therapy, as applied to clinical overdosage with NSAIDs should be applied. Use in aged dogs may involve additional risk. If such a use cannot be avoided, dogs may require careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated. Typical undesirable effects associated with NSAIDs such as vomiting, soft faeces/diarrhoea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events. For more information, please use the following link: https://www.noahcompendium.co.uk/?id=-468552
